PSC
NTUS

Piper Sandler & Co’s Natus Medical Inc NTUS Stock Holding History

Piper Sandler & Co’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,500
Closed -$493K – 82
2015
Q3 		$493K Buy
+12,500
New +$531K 0.53% 16

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.21B AUM 49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Piper Sandler & Co's NTUS Position: Q4 2015 in Review

Piper Sandler & Co sold out of Natus Medical Inc (NTUS) in Q4 2015, closing a stake of 12,500 shares — an estimated $493K sold.

Piper Sandler & Co first reported a position in NTUS in Q3 2015 and held it in 1 quarter. The position peaked at $493K in Q3 2015. 212 funds tracked by Wall St. Rank hold NTUS as of Q4 2015.

  • Piper Sandler & Co reported no remaining Natus Medical Inc position as of Q4 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 12,500 Natus Medical Inc shares in Q4 2015, an estimated $493K.
  • Piper Sandler & Co first reported a position in Natus Medical Inc in Q3 2015 and held it in 1 quarter.
  • Piper Sandler & Co's Natus Medical Inc position peaked at $493K in Q3 2015.
  • 212 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.